Maribavir Treatment for Resistant Cytomegalovirus Infection in Pediatric Kidney Recipients: Two Case Reports (ATC 2026) - Jun 17, 2026 - Abstract #Abstract B223; Pres time: Jun 21, 2026; 02:45 PM - 03:45 PM; Location: Exhibit Hall; "Classical treatment with ganciclovir failed to obtain complete viral suppression. These cases support the efficacy and good tolerance of using maribavir for the treatment of resistant CMV infections in pediatric kidney transplant recipients. Nevertheless, larger pediatric studies are needed to confirm the safety, and optimal management of these therapies in this specific population."
Case report • Clinical • Cytomegalovirus Infection • Hematological Disorders • Infectious Disease • Pediatrics
|
|
E. Cheyssac 1; A. Sellier-Leclerc 2; F. Louillet 3; J. Hogan 4
|